00773nas a2200253   4500000000100000008004100001100001300042700001600055700001500071700001500086700001600101700001600117700001600133700001200149700001300161700001300174700001600187700001500203700001500218245024400233250002100477300001300498490000800511       2013                            d1 aRyden L.1 aNicholls S.1 aGrobbee D.1 aLincoff A.1 aTardif J-C.1 aSchwartz G.1 aMalmberg K.1 aBuse J.1 aHenry R.1 aWedel H.1 aWeichert A.1 aCannata R.1 aNeal Bruce00aEvaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial.  aEpub 2013 Jul 26  a429-34. 0 v166